The Global Central Venous Catheter Market Is Expected To Be Worth US$ 2,117.8 Million In 2021, With A CAGR Of 6.2% Over The Forecast Period (2021-2028)

Central Venous Catheter Market
Central Venous Catheter Market

A central line or central venous line is another name for a central venous catheter. It is a flexible tube that is inserted into the vein beneath the right side of the collarbone and guided to the superior vena cava, a large vein that leads to the heart. A central venous catheter is used to administer various fluids that can be easily injected into the patient's bodies. Intravenous fluid, blood transfusions, and chemotherapy drugs are among the fluids.

In 2011, the Centers for Disease Control and Prevention (CDC) issued guidelines for preventing intravascular catheter-related infections, which were updated in 2017. The guideline covers a variety of important aspects related to the central venous catheters Central Venous Catheter Market, such as appropriate training for healthcare personnel who insert intravascular catheters and staff who are responsible for catheter and catheter application site surveillance and selection.

Over the forecast period, the COVID-19 pandemic is expected to limit growth in the global Central Venous Catheter Market.

For example, in June 2020, a study published in Current Oncology, a Canadian Cancer Research Journal, examined the impact of the COVID-19 outbreak in China on Stage II and Stage III colon cancer patients receiving adjuvant chemotherapy treatment. The patients had to postpone or modify their chemotherapy regimens during the COVID-19 outbreak for the following reasons, according to the study: Hospitalization policies changed during the pandemic. Transportation disruption as a result of the lockdown Patient's unwillingness. Side effects include vein blockage, among other things.

Furthermore, the decrease in blood transfusions is expected to impede the growth of the global Central Venous Catheter Market. For example, an article published in the journal Transfusion Medicine and Hemotherapy in November 2021 stated that during the COVID-19 pandemic, more challenges for blood transfusion arose as a result of lockdown, social distancing, and fear of blood virus transmission. Furthermore, the elderly, who contributed the most to blood donations, were among the most vulnerable to the virus, resulting in lower donations from them, according to the same source.

Comments

Popular posts from this blog

Security Robot Market to Reach US$ 11.8 Billion by 2022

Intravenous Fluid Therapy is the Fastest Growing Segment Fueling the Growth of Intravenous Solutions Market

Global Report on LED Driver Market for the Forecast Period 2023-2030